Sponsors of our previous Conferencies

Partners & Sponsors

Fifth Early Fetal Scan Conference:

EARLY SCREENING & DIAGNOSIS of FETAL ANOMALIES:
Total Reimagination of Current Clinical Practice

22-23 & 29-30 October 2022

FIFTH EARLY FETAL SCAN GLOBAL ONLINE CONFERENCE

is generously supported by

GE Healthcare is the $19 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

Astraia.software provides digital solutions for all OB/GYN professionals for easy documentation and reporting with advanced medical functionalities, covering all aspects of women’s and fetal health.

With the Obstetrics module you can monitor the health of mother and child from early pregnancy on through to delivery and easily document all examinations from routine checks to highly specialized procedures. Our sophisticated Fetal Echocardiography module allows specialists to systematically and precisely assess the fetal heart.
Several integrated calculators and algorithms help evaluate measurement data, like the first trimester risk assessment (FMF UK) or growth monitoring. Extensive help files are at your fingertips as medical reference or educational resource.

NEXUS / ASTRAIA GmbH (former astraia software GmbH) is your expert in e-health for Obstetrics and Gynaecology.

London School of Ultrasound delivers advanced Ultrasound courses medical professionals since 2017.

Our mission – to implement early prenatal diagnosis of cardiac anomalies worldwide by training of doctors and sonographers.
We believe that cardiac anomalies should be the most important target for Fetal Ultrasound while Fetal echocardiography plays a key role in the early diagnosis of Congenital Heart Defects.